To investigate the mechanisms underlying the proinflammatory effects of bradykinin, we used intravital microscopic techniques to examine leukocyte/endothelial cell adhesive interactions and venular protein leakage in single postcapillary venules of the rat mesentery.
INTRODUCTION
The neuropeptide bradykinin is well known for its actions as an endothelium-dependent vasodilator. Bradykinin induces relaxation of vascular smooth muscle via stimulation of B 2 receptors which in turn stimulates constitutively expressed endothelial nitric oxide (NO) synthase (eNOS) to produce NO, induces cyclooxygenase-dependent production of prostacyclin and other prostanoids, as well as superoxide, activates charybdotoxin-sensitive K + channels, and induces the formation of epoxyeicosatrienoic acids by cytochrome P450 epoxygenase (7, 8, 16, 18, 21, 65) . In addition to its actions on arterial and arteriolar vascular smooth muscle, bradykinin also exerts powerful proinflammatory effects in postcapillary venules. For example, the neuropeptide causes the formation of interendothelial gaps and increased protein leakage, generates the release of endothelial-derived mediators from cultured endothelial cells that are chemotactic for neutrophils, eosinophils, monocytes, and pulmonary alveolar macrophages, induces the expression of endothelial adhesion molecules, and provokes leukocyte adherence to endothelial monolayers and postcapillary venules (1, 3, 11, 17, 25, 41, 43, 45, 53, (55) (56) (57) (58) (59) .
In contrast to the large number of studies directed at elucidating the vasodilatory mechanisms of bradykinin in arteries and arterioles, comparatively less attention has been devoted to evaluation of the signaling pathways that underlie the proinflammatory effects of the neuropeptide in postcapillary venules. Indeed, our understanding of the mechanisms underlying the effect of bradykinin to produce leukosequestration is particularly inadequate. This latter question is espeically intriguing in light of the fact that bradykinin induces the production of endothelium-derived mediators that exert powerful anti-inflammatory effects (eg, NO, prostacyclin, and epoxyeicosatrienoic acids) (8, 16, 36, 37, 48, 51) . Thus, the aim of present study was to explore the mechanisms whereby bradykinin disrupts microvascular barrier function and induces leukocyte rolling, adhesion, and emigration in postcapillary venules. To this end, we examined the effects of NO synthase or cyclooxygenase blockade, mast cell or cytoskeletal stabilization, oxidant scavenging, xanthine oxidase, NADPH oxidase, or cytochrome P450
epoxygenase inhibition, and protein kinase C (PKC) inhibition on bradykinin-induced leukocyte adhesion and venular protein leakage. The molecular determinants of bradykinin-induced leukocyte/endothelial cell adhesive interactions were also interrogated by use of monoclonal antibodies directed against P-selectin and intercellular adhesion molecule-1 (ICAM-1).
METHODS

Surgical Procedure
Male Sprague-Dawley rats (200 to 250 g) were maintained on a purified laboratory diet and fasted for 24 hours before the experiment. The animals were initially anesthetized by intraperitoneal injection of pentobarbital (65 mg/Kg body wt). Upon attaining a surgical level of anesthesia, a tracheotomy was performed to facilitate breathing during the experiment. The right carotid artery was cannulated and systemic arterial pressure was measured with a Statham P23A pressure transducer connected to the carotid artery catheter. Systemic blood pressure was continuously recorded with a personal computer (Macintosh 8500, Apple)
equipped with an analog-to-digital converter (MP 100, Biopac Systems). The left jugular vein was also cannulated for administration of the anti-adhesion monoclonal antibodies. Following these procedures, a midline abdominal incision was performed to allow for exteriorization and intravital microscopic examination of a section of the mesentery from the small intestine.
Intravital Microscopy
The rats were positioned on a 20 x 30 cm Plexiglas board in a manner that allowed a selected section of mesentery to be placed over a glass slide covering a 4 x 3 cm hole centered in the Plexiglas. The mesentery was superfused at 2.5 ml/min with bicarbonate-buffered saline (BBS, pH 7.4) bubbled with a mixture of 5% CO 2 and 95% N2 to reduce the oxygen tension to the physiological intraperitoneal level (40 to 50 mm Hg). The exposed bowel wall was covered with BBS-soaked gauze to minimize tissue dehydration. Venular blood flow was calculated from the product of mean red blood cell velocity and microvascular cross-sectional area, with cylindrical geometry assumed (Vmean = centerline velocity/1.6) (13). Venular wall shear rate (SR) was calculated from the Newtonian definition: SR = 8(Vmean/Dv). The number of rolling, stationary (firmly adherent), and emigrated leukocytes was determined off-line during playback of videotaped images. A leukocyte was considered to firmly adherent to venular endothelium if it remained stationary for 30 seconds or longer (23, 24) .
Adherent leukocytes were quantified as the number per 100 µm length of venule. Leukocyte emigration was expressed as the number per field of view surrounding the venule. A rolling leukocyte was defined as a white cell that moved slower than the stream of flowing erythrocytes.
Leukocyte rolling velocity was determined from the time required for a leukocyte to traverse a 100-µm distance along the length of the venule and is expressed as micrometers per second.
The flux of rolling leukocytes was measured as those white cells that could be seen moving within a small (25-µm) viewing area of the vessel with the same area used throughout the experiment.
To quantify albumin leakage across mesenteric venules, 50 mg/Kg of flurescein isothiacyanate (FITC)-labeled bovine albumin (Sigma) was administered intravenously to the animals 15 minutes before the baseline recording (35, 37) . Fluorescence intensity (excitation wavelength, 420 to 490 nm; emission wavelength, 520 nm) was detected with a CCD camera (XC-77, Hamamatsu Photonics), a CCD camera control unit (C2400, Hamamatsu Photonics), and an intensifier head (M4314, Hamamatsu Photonics) attached to the camera. The fluorescence intensity of the venule under study (Iv), the fluorescence intensity of contiguous perivenular interstitium within 10 to 50 µm of the venular wall (Ii), and the background fluorescence (Ib) were measured at various times after the administration of FITC-albumin with a computer-assisted digital imaging processor (NIH Image 1.56b on a Macintosh computer). The windows to measure average fluorescence intensities within and along the venule were set at 20-µm length and 10-µm width. An index of vascular albumin leakage (VPL) was determined from the relation (Ii-Ib)/(Iv-Ib).
Experimental Protocols
After a stabilization period of 30 minutes, images from the mesenteric preparation were recorded on videotape for 10 minutes (baseline recording). Thereafter, bradykinin was topically applied for 60 min to the exposed region of the mesentery via the superfusate. Video recordings were made during minutes 20 to 30 and minutes 50 to 60 of bradykinin superfusion.
Hemodynamic measurements (ie, venular diameter, erythrocyte velocity, and mean arterial blood pressure) and recording of fluorescence images (<10 seconds) were made at the end of each video recording. In the first series of experiments, the mesentery was superfused for 60 minutes with different concentrations of bradykinin (0.01, 0.1 or 1 µM). In an earlier study (59),
we observed that higher concentrations of bradykinin (ie, 10 µM), resulted in blood flow stasis in the venule under observation, an effect which was associated with a marked increase in the number of circulating platelet-leukocyte aggregates. Thus, the maximal concentration of bradykinin we examined in the present study was 1 µM. In the second series of experiments, the mesentery was superfused with 1 µM bradykinin for 60 minutes in the presence of an NO synthase inhibitor, L-NAME, at 10 µM (Sigma), a cyclooxygenase inhibitor, indomethacin, at 10 and Go-6976 (14, 42) .
Statistical Analysis
The data were analyzed with standard statistical analyses, ie, ANOVA with Scheffé's (post hoc) test. All values are reported as mean±SEM. Statistical significance was set at P<0.05. The number of observations for each variable in each group was obtained from 6 to 9 rats. Since oxidants activate PKC and this family of kinases has been implicated in the effect of bradykinin to increase microvascular permeability (6, 22, 46, 54) , we sought to determine whether this kinase family also participated in bradykinin-induced leukocyte infiltration. Superfusion of the mesentery with chelerythine (+Chelerythrine), a pan PKC antagonist, prevented the effects of bradykinin to increase leukocyte/endothelial cell adhesive interactions and venular protein leakage ( Figure 4A-4D ). Whereas the latter observations support a role for PKC in the signaling cascade induced by bradykinin, they do not provide insight regarding the class of PKC isoforms involved because chelerythrine blocks the activity of all PKC isotypes. To determine the role of calcium-dependent (classical or conventional) PKC isotypes in the proinflammatory effects of bradykinin, we treated the mesentery with Go-6976 (+Go-6976), a highly selective antagonist of the classical isoforms PKC-α and PKC-BI that exhibits no activity towards the novel isotypes PKC-δ or PKC-ε, even at millimolar concentrations (42) . Go-6976 was as effective as chelerythrine in preventing the effects bradykinin to increase venular protein leakage and leukocyte rolling, adhesion, and emigration ( Figure 4A-4D ).
RESULTS
Figure
The effect of bradykinin superfusion at 0.01, 0.1, or 1 µM on venular diameter, erythrocyte velocity, and mean arterial blood pressure are summarized in Table 1 . Topical application of bradykinin did not alter the venular diameter or mean arterial blood pressure at any dose, but significantly decreased erythrocyte velocity when superfused at 1 µM ( (1, 3, 6, 11, 17, 41, 43, 46, 54) , there are still large gaps in our understanding of the mechanism involved in this inflammatory response to the peptide. Thus, the major aims of this study were to begin to identify the signaling pathways whereby bradykinin induces leukocyte rolling, adhesion, and emigration and to expand our understanding of the mechanisms underlying the effect of the peptide to increase protein extravasation.
We observed that superfusion of the mesentery with bradykinin for 60 min increased the number of rolling, firmly adherent (stationary), and emigrated leukocytes in a manner that appeared to be concentration-and time-dependent (Figure 1 ). The bradykinin-induced leukocyte/endothelial cell adhesive interactions were associated with a decrease in venular erythrocyte velocity without a change in mean arterial blood pressure or venular diameter.
These results are qualitatively similar to those we reported in an earlier study (59) The divergent results reported in the present versus our previous study (59) suggest that bradykinin-induced leukocyte adhesion and emigration occurs via a time-dependent mechanism with the initial phase (≤15 min) being PAF-dependent and later phases (≥30-60 min) being PAFindependent.
We examined the role of mast cell-derived mediators by superfusing mesenteries with tranilast, a mast cell stabilizer (47) . This notion was based on the facts that bradykinin can cause mast cell degranulation and many of the secreted substances (eg, histamine and serotonin) are not only vasoactive but also induce leukocyte adherence and increase microvascular permeability (39, 40, 62) . Tranilast attenuated the increase in the number of rolling leukocytes, a result which indicates that the agent remained effective over the 60 min protocol (Figure 2) . However, mast cell stabilization failed to prevent leukocyte adhesion and emigration induced by bradykinin (Figure 2 ). While these results indicate that the degranulation of mast cells may lead to the release of mediators that promote leukocyte rolling in postcapillary venules of the rat mesentery, mast cell-derived mediators do not appear to play an important role in the bradykinin-induced leukocyte adhesion and emigration.
Bradykinin has been reported to stimulate the formation of superoxide by cultured endothelial cells (27, 60) and inhibitor studies indicate that superoxide generation contributes to the vascular effects of bradykinin in vivo (64) . Based on these observations, we hypothesized that bradykinin-induced superoxide formation may play a role in its proinflammatory effects in our model. This postulate is especially appealing in light of the facts that superoxide has been implicated in the increased leukocyte adhesion induced by ischemia/reperfusion (23, 24) and xanthine oxidase-derived superoxide (and other secondarily-derived oxidants) promote the adherence of granulocytes to the microvascular endothelium (63) . To address this issue, rats were treated with either superoxide dismutase (SOD, a highly specific superoxide scavenger), a cell-permeant SOD mimetic (Mn-TBAP), or mercaptoproprionyl glycine (MPG), an antioxidant that also readily crosses cell membranes. While SOD was not effective in preventing the proadhesive effects of bradykinin, Mn-TBAP and MPG markedly attenuated the increase in leukocyte adhesion and emigration induced by the peptide (Figure 3 ). These apparently disparate results may be explained by the fact that SOD does not readily cross cell membranes (and thus is largely confined to the extracellular space following intravenous administration) whereas both Mn-TBAP and MPG can gain access to the intracellular compartment. Thus, our results are consistent with the view that bradykinin induces leukocyte adhesion and emigration by a mechanism that involves oxidant generation at an intracellular site. This conclusion is supported by the work of Wolin and coworkers (66) who demonstrated that the vasodilator responses to bradykinin do not involve extracellular oxidant generation. Moreover, bradykinininduced vascular relaxation is reduced in vessels exposed to an inhibitor of cytosolic Cu/Znsuperoxide dismutase and enhanced by cell-permeant SOD mimetics (64), observations which also point to an intracellular oxidant source being activated by bradykinin.
In light of the aforementioned findings supporting a role for oxidants in the proadhesive effects of bradykinin, we next attempted to determine the source for their production. It is wellknown that bradykinin can promote the formation of superoxide as a result of cyclooxygenase activation (67). In addition, NO synthase is activated by ligation of bradykinin B 2 receptors and can produce superoxide under certain conditions (67) . Moreover, it is also possible that the generation of chemotactic stimuli may occur secondary to concomitant activation of NO synthase and cyclooxygenase by bradykinin. That is, bradykinin may induce the simultaneous formation of NO and superoxide by stimulating these enzymes. NO and superoxide may interact to form the powerful oxidants, peroxynitrite and hydroxyl radicals, which may exert proinflammatory effects in their own right but may also participate in the formation of chemotactic stimuli. Indeed, bradykinin has been shown to induce the simultaneous formation of superoxide and NO in canine basilar arteries (64) . However, treatment with indomethacin (cyclooxygenase inhibitor) or L-NAME (NO synthase inhibitor) proved to be ineffective in inhibiting the bradykinin-induced leukocyte recruitment ( Figure 2 ).
Although our L-NAME data argues against a role for NO in bradykinin-induced venular protein leakage in the rat mesentery, work conducted in the hamster cheek pouch indicates that this NO synthase antagonist prevents the effect of the neuropeptide to cause protein extravasation (17, 43) . While it is not clear why our results in rat mesentery differ from those reported in hamster cheek pouch, it is likely that differences in tissues, species, time-course for bradykinin exposure, and/or method for assessing endothelial barrier function may account for the discrepant results.
Since our results did not support a role for the generation of radical species from cyclooxygenase or NO synthase, we examined the contribution of two other well-known sources of superoxide, xanthine oxidase and NAD(P)H oxidase, to the proinflammatory effects of bradykinin. Both enzymes are present in the vascular wall and NADPH oxidase is activated in stimulated neutrophils (26, 50) . In addition, there is some evidence for xanthine oxidase activation by bradykinin (15) . However, this latter notion is controversial, with other studies indicating that the peptide does not promote an increase in xanthine oxidase activity (20) . Our results fail to support a role for either enzyme since neither xanthine oxidase inhibition with oxypurinol nor treatment with PR-39, a proline/arginine-rich peptide that inhibits NADPH oxidase, were effective in preventing the proinflammatory effects of bradykinin (Figure 3) . Thus, xanthine oxidase and NAD(P)H oxidase do not appear to play a role in generating the oxidant species that mediate the proinflammatory effects of bradykinin.
Recent work indicates that bradykinin elicits the production of reactive oxygen species in endothelial cells via activation of cytochrome P450 2C9 (CYP 2C9) (19) . To test for a role for this endothelium-derived hyperpolarizing factor synthase in the inflammatory responses to bradykinin, we evaluated the effect of a selective CYP 2C9 inhibitor, sulfaphenazole, on bradykinin-induced leukocyte/endothelial cell adhesive interactions and venular protein leakage.
Coincident treatment with sulfaphenazole prevented the inflammatory responses to bradykinin ( Figure 3 ). While these observations support the notion that CYP 2C9 may be a source of the reactive oxygen species that initiate the proinflammatory effects of bradykinin, this enzyme also catalyzes the formation of epoxyeicosatrienoic acids (EETs) (19, 48) . However, it is unlikely that EETs contribute to the proinflammatory effects of bradykinin because these CYP epoxygenase- induced by bradykinin confirms and extends these earlier observations (Figure 4 ). An important new finding of the present study is that bradykinin-induced PKC activation also participates in the effect of the peptide to recruit leukocytes. Our studies also provide novel insight regarding the PKC isotypes involved in the proinflammatory effects of bradykinin. That is, our data indicates that the effects of bradykinin involve the calcium-dependent or classical isotypes of the enzyme. The latter notion is based on the observation that Go-6976, a PKC antagonist that exhibits a high degree of specificity for the classical isotypes PKC-α and PKC-BI but demonstrates no inhibitory activity towards the novel, calcium-independent isoforms (eg, PKC-δ or PKC-ε) even at millimolar concentrations (42), was as effective as chelerythrine in preventing the effects of bradykinin to promote leukocyte adhesion and microvascular barrier dysfunction ( Figure 4 ). This conclusion is supported by the observation that bradykinin causes the translocation of PKC-α from the cytosolic to membrane fraction in cultured human umbilical vein endothelial cells (54) . The demonstrated role for PKC is also consistent with our tranilast data in that bradykinin-induced mast cell mediator release occurs by a PKC-independent mechanism (12). Thus, if mast cells were involved in the effects of bradykinin to increase venular protein leakage and leukocyte adhesion, which our data argues against, then one would have expected that PKC inhibition would be ineffective in preventing these actions of the peptide, which was not the case.
Although the molecular targets of bradykinin-induced PKC-α-dependent phosphorylation are uncertain, it has been suggested that cytoskeletal proteins may represent downstream elements in the activation process (54) . This notion is appealing with regard to work indicating that cytoskeletal proteins play an important role in the activation and expression of adhesion molecules and in the regulation of endothelial barrier function (3, 5, 31, 41) . To address this issue, we administered phalloidin, a bicyclic heptapeptide derived from the green-capped mushroom Amanita phalloides which acts to induce the assembly of F-actin as well as to stabilize existing actin filaments in microfilamentous cytoskeletal elements. We have previously exploited these properties of phalloidin to evaluate the role of endothelial cytoskeletal reorganization in the leukocyte infiltration and microvascular barrier disruption induced by PAF, leukotriene B 4 , FMLP or ischemia/reperfusion (3, 5, 31) . A significant new finding of the present study is that phalloidin attenuated leukocyte rolling and completely prevented leukocyte emigration and albumin leakage induced by bradykinin, without affecting the firm (stationary)
adhesive interactions between white cells and the postcapillary venular endothelium that occur as a result of B 2 receptor activation ( Figure 2 ).
We can only speculate as to the mechanism whereby phalloidin attenuated bradykinininduced leukocyte rolling and prevented leukocyte emigration and microvascular barrier disruption. Since leukocyte rolling is dependent on P-selectin expression, stabilizing F-actin in endothelial cells may limit bradykinin-induced mobilization of this adhesive ligand from WeibelPalade bodies to the cell surface (5). The fact that phalloidin prevents the changes in endothelial cell shape required for diapedesis may explain its ability to prevent bradykinininduced leukocyte emigration and microvascular barrier disruption (3, 5, 31) . Stabilizing F-actin in endothelial cells may also prevent alterations in the organization of junctional proteins, thereby limiting diapedesis and venular protein leakage (3). Since leukocyte rolling has been suggested to be mandatory for subsequent adhesion and emigration, it might be viewed as surprising that phalloidin failed to influence bradykinin-induced stationary adhesion, given its effect to reduce rolling by 60-70%. However, Kubes and coworkers (34) have demonstrated that leukocyte rolling must be inhibited by >90% to achieve significant reductions in leukocyte adhesion.
Our results also indicate that bradykinin-induced leukocyte adhesion and emigration depend on the expression of specific adhesion molecules, P-selectin and ICAM-1. Although Pselectin antibody treatment blocked bradykinin-induced leukocyte rolling as well as leukocyte adhesion and emigration, immunoneutralization of ICAM-1 blocked only stationary adhesion and emigration ( Figure 2 ). Since leukocyte rolling is a prerequisite to establishing stationary adhesive interactions, these observations are compatible with the notion that bradykinin-induced leukocyte rolling is P-selectin-dependent while firm adhesion is mediated by ICAM-1.
Consistent with this concept is the observation that intraperitoneal administration of bradykinin upregulates P-selectin expression in rat gastrointestinal organs (55) . Bradykinin-induced oxidant formation may contribute to the expression of P-selectin, since surface expression of this adhesive glycoprotein can be upregulated by reactive oxygen species (2).
Since there is persuasive evidence suggesting that there is a causal link between mediatorinduced leukocyte emigration and vascular protein leakage (38) , it was surprising that immunoneutralization of P-selectin or ICAM-1, an approach that completely abolished the leukocyte adhesion and emigration induced by bradykinin, did not inhibit venular albumin leakage ( Figure 2 ). These findings indicate that the microvascular barrier disruption caused by bradykinin occurs by a mechanism that is leukocyte-independent. This concept is supported by in vitro studies wherein bradykinin induces a reorganization of cytoskeletal elements and disrupts barrier function of endothelial monolayers in the absence of neutrophils (3, 54) . In addition, Norman et al (49) have shown that monoclonal antibodies directed at CD18 or ICAM-1 do not prevent edema formation produced by bradykinin in rabbit skin.
Several methodological considerations warrant some attention. For example, it may be argued that L-NAME, WEB 2086, tranilast, PR-39 and/or SOD may have become ineffective over the prolonged protocol used in the present study. However, this potential explanation for the lack of effect of these agents on leukocyte adhesion is unlikely for at least two reasons.
First, L-NAME, WEB 2086, and tranilast were continuously applied to the mesenteric venule under observation throughout the protocol. In addition, the circulating half-life of SOD is increased from 8 min to nearly 2 hrs by ligating the renal vascular pedicle (32) prior to its administration, as we did. Renal vascular ligation would also be expected to increase the circulating half-life of PR-39 (30) . Thus, it is not likely that drug metabolism or renal elimination accounts for the lack of effect of these agents. Second, using the same model (rat mesentery) and protocol for antagonist delivery (continuous application via the superfusate) that we have employed in the present study, Granger and coworkers (4, 33, 37) have been able to show that superfusion with WEB 2086 prevents leukocyte adhesion and venular protein leakage induced by 60 min (the same time frame over which we observed the responses to bradykinin) NO synthase inhibition or by ischemia followed by 60 min reperfusion. Thus, WEB 2086 effectively prevented PAF-induced effects associated with I/R and NO synthase inhibition in the rat mesentery over the same period of time that the rat mesentery was exposed to bradykinin in our studies, where the inhibitor had no effect. Similar arguments apply to the data obtained with L-NAME, SOD, oxypurinol, PR-39, indomethacin, and mast cell stabilization (28) (29) (30) 33, 50) .
In summary, exposing the rat mesentery to bradykinin at concentrations ≥0.1 µM for 60 min increased the number of rolling, firmly adherent, and emigrated leukocytes in single postcapillary venules. These bradykinin-induced leukocyte/endothelial adhesive interactions occurred by a B2-receptor-initiated, oxidant-and PKC-mediated, P-selectin-and ICAM-1-dependent mechanism. Similar concentrations of bradykinin also produced venular protein extravasation. While this latter effect was also initiated by B2 receptor activation, involved oxidant generation, PKC activation and disruption of microfilamentous actin, bradykinin-induced microvascular barrier disruption was independent of leukocyte adherence and emigration. 
